FitLife Brands, Inc.

FitLife Brands, Inc. Q3 2025 Earnings Recap

FTLF Q3 2025 November 14, 2025

Get alerts when FTLF reports next quarter

Set up alerts — free

FitLife Brands reported a robust 47% year-over-year revenue increase in Q3 2025, driven significantly by the recent acquisition of Irwin Naturals, although gross margins faced pressure from increased costs and the integration of the new brand.

Earnings Per Share Miss
$0.19 vs $0.25 est.
-24.0% surprise
Revenue Miss
23485000 vs 23875000 est.
-1.6% surprise

Market Reaction

1-Day -2.01%
5-Day -0.46%
30-Day -11.44%

See FTLF alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Total revenue reached $23.5 million, with Irwin Naturals contributing $6.8 million despite only 53 days of operations.
  • Legacy FitLife's organic growth was 8% excluding MRC, while MusclePharm delivered an impressive 55% organic growth, driven by a 112% increase in wholesale revenue.
  • Gross margin declined to 37.2%, reflecting lower margins in the MusclePharm brand and the impact of Irwin, though adjusted gross margin was more favorable at 38.9% excluding inventory step-up amortization.
  • Net income fell to $0.9 million, impacted by acquisition-related expenses and a higher effective tax rate.
  • Wholesale revenue soared by 156% year-over-year, indicating strong distribution channels and potential for continued growth post-acquisition.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit FTLF on AllInvestView.

Get the Full Picture on FTLF

Track FitLife Brands, Inc. in your portfolio with real-time analytics, dividend tracking, and more.

View FTLF Analysis